Landiolol, an ultra-short-acting β1-blocker, is useful for managing supraventricular tachyarrhythmias in sepsis

Figure 1 Heart rate and sinus rhythm conversion rate. Rapid and substantial reduction of heart rate (HR) was observed in the landiolol group. Reduction in HR was observed in the landiolol group than the control. In addition, the conversion from supraventricular arrhythmia to sinus rhythm was observed more frequently in the landiolol group than in the control group at every point. Results are expressed as mean ± SE. ^aP < 0.01, ^bP < 0.05 vs time 0 h.

Figure 2 Arterial pressure. Landiolol did not change atrial blood pressure. Results are expressed as mean ± SE.

Figure 3 Pulmonary arterial catheter parameters. Landiolol did not affect diastolic pulmonary arterial pressure or cardiac index. Results are expressed as mean ± SE.